Expands the existing law regarding collaborative practice agreements between pharmacists and physicians to allow other healthcare providers to enter into such agreements and removes the definition of “collaborative practice committee.”
Plain English Summary
AI-generatedPlain-English Summary
Currently, Rhode Island law allows pharmacists and physicians (medical doctors) to enter into formal working arrangements called "collaborative practice agreements." These agreements let pharmacists take on expanded roles in patient care — such as adjusting medication doses or managing drug therapies — under the supervision and guidance of a physician. This bill would broaden that existing law to allow pharmacists to enter into these same types of agreements with a wider range of healthcare providers, not just physicians.
Under this bill, other licensed healthcare professionals — such as nurse practitioners or other qualified providers — could partner with pharmacists through these formal agreements. This means patients could receive more coordinated medication management from a broader team of healthcare professionals. The bill also removes a specific term from the law — the definition of "collaborative practice committee" — which appears to be a technical cleanup to simplify the legal language.
This change would primarily affect pharmacists, physicians, and other healthcare providers in Rhode Island, as well as the patients they serve. For patients, especially those managing chronic conditions or complex medication regimens, this could mean more flexible and accessible care, since a greater variety of healthcare providers could authorize pharmacists to play a more active role in their treatment. The bill has been moving through the legislative process, with a committee recommending its passage as of early 2026.
This summary is AI-generated for informational purposes. Always refer to the official bill text for legal accuracy.
Sponsors
Legislative History
Committee recommends passage
Mar 30, 2026Scheduled for consideration (03/30/2026)
Mar 26, 2026Committee recommended measure be held for further study
Mar 3, 2026Scheduled for hearing and/or consideration (03/03/2026)
Feb 27, 2026Meeting postponed (02/24/2026)
Feb 23, 2026Scheduled for hearing and/or consideration
Feb 19, 2026Introduced, referred to House Health & Human Services
Jan 30, 2026